全球甲状腺癌诊断市场

预计到 2030 年全球甲状腺癌诊断市场规模将达到 67 亿美元

全球甲状腺癌诊断市场规模预计在2024年为53亿美元，预计到2030年将达到67亿美元，2024年至2030年的复合年增长率为3.7%。作为报告分析的细分市场之一，仪器仪表市场预计将以3.0%的复合年增长率成长，并在分析期结束时达到40亿美元。耗材及配件市场在分析期间的复合年增长率预计为4.9%。

美国市场预计将达到 15 亿美元，中国市场复合年增长率将达到 6.8%

美国甲状腺癌诊断市场规模预计在2024年达到15亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到13亿美元，在2024-2030年的分析期间内，复合年增长率为6.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.5%和2.8%。在欧洲，预计德国市场的复合年增长率为2.1%。

全球「甲状腺癌诊断」市场—主要趋势与驱动因素摘要

精准肿瘤学时代甲状腺癌诊断如何发展？

在分子生物学、影像和个人化医疗进步的推动下，甲状腺癌诊断领域正在发生重大变革时期。甲状腺癌检测过去依赖触诊、超音波和细针抽吸 (FNA)，现在越来越多地得到基因组分析、生物标记分析和高解析度成像的支持。这些工具正在提高诊断准确性，减少不必要的手术，并能够更早发现恶性肿瘤，如乳头状和滤泡性甲状腺癌。使用次世代定序仪(NGS) 面板识别 BRAF、RAS、RET 和 TERT 等基因突变，正在彻底改变临床医生区分结节是良性还是恶性的方式，尤其是在细胞学结果不确定的病例中。放射组学和基于人工智慧的超音波数据解释也提高了传统成像的预测价值，使临床决策更加自信。液态切片虽然仍处于起步阶段，但有望实现对疾病进展和復发的非侵入性、可重复监测。这些创新不仅提高了诊断的准确性，而且还支持了标靶治疗和个人化治疗计划的更广泛趋势。

甲状腺癌发生率上升会改变全球诊断重点吗？

全球甲状腺癌发生率持续上升，部分原因是诊断影像技术的普及和认知度的提升，尤其是在医疗保健系统先进的地区。这一流行病学趋势促使公共卫生系统和临床诊所优先考虑甲状腺结节的早期发现和鑑别诊断。虽然甲状腺结节的增加很大程度上是由于发现小型低度肿瘤，但对过度诊断和过度治疗的担忧正促使人们转向更细緻的诊断框架。新兴指南提倡一种风险分层诊断方法，结合影像学、细胞学和分子检测来客製化病患管理。在亚洲，尤其是韩国和中国，患者数量的成长促使国家加强筛检力度，并增加对诊断基础设施的投资。同时，随着医疗保健意识和可近性的提高，非洲和拉丁美洲部分地区对诊断工具的需求正在落后。这些全球性转变正在重塑诊断工作流程，并加剧对经济高效、扩充性且微创技术的需求。

哪些诊断技术正在成为甲状腺癌检测的新标准？

随着影像、细胞病理学和分子诊断等创新技术的出现，甲状腺癌的诊断设备正在迅速扩展。高频超音波仍然是初步评估的基石，但弹性成像、多普勒血流分析和分析结节形态和血管分布的机器学习演算法显着提高了其诊断准确性。细针抽吸切片检查是细胞学评估的黄金标准，目前正在与评估基因突变和表现图谱的分子检测平台互补。 ThyroSeq、Afirma 和 RosettaGX 等市售检测方法为不确定结节的恶性肿瘤风险提供了宝贵的见解，并指南是否有必要进行手术。 SPECT/CT 和 PET/CT 影像在分期、復发监测和治疗反应评估中发挥越来越重要的作用，尤其是在高风险和转移性病例中。人工智慧驱动的病理学平台正在提高细胞学解释的一致性并降低观察者间的差异。在尖端技术方面，对血液中循环肿瘤DNA (ctDNA) 和微型RNA特征的研究有望拓展非侵入性监测的新领域。这些创新正在推动甲状腺癌诊断迈向精准、高效和个人化的未来。

甲状腺癌诊断市场的成长受到多种因素的推动。

甲状腺癌诊断市场的强劲成长受到技术、人口和医疗政策等因素的推动。全球甲状腺结节数量的不断增加——其中许多需要透过先进的诊断技术进行鑑别——是主要的临床驱动因素。超音波和电脑断层扫描等高解析度影像技术的广泛应用，正在发现更多偶然发现的甲状腺结节，其中许多结节需要转诊诊断。分子诊断和基因组分析在常规临床实践中的日益普及，使得对不确定病例的评估更加准确，从而减少了诊断的不确定性并改善了患者管理途径。此外，临床指南转向基于风险的个人化甲状腺结节评估方法，这鼓励医院和诊断实验室投资于整合诊断平台。患者对非侵入性精准诊断的需求也影响液态切片和先进影像工具的采用。人口老化、新兴国家医疗服务可近性的提高以及对内分泌癌症认识的不断提高，进一步推动了诊断数量的增长。此外，基于价值的护理和结果最佳化趋势正在推动医疗保健提供者采用技术来减少不必要的程序并提高诊断准确性，从而增强了晚期甲状腺癌诊断的市场动能。

部分

产品类型（仪器、耗材、配件）；检测类型（影像检查、切片检查、血液检测、其他检测类型）；最终用户（医院、附属实验室、独立诊断实验室、影像中心、癌症研究机构、其他最终用户）

受访公司范例（值得关注的32家公司）

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Canon Inc.
• Cepheid
• DiaSorin SpA
• Eli Lilly and Company
• FUJIFILM Holdings Corporation
• GE HealthCare
• Hologic Inc.
• Illumina Inc.
• Koninklijke Philips NV
• Labcorp
• Merck KGaA
• Myriad Genetics Inc.
• QIAGEN NV
• Quest Diagnostics Inc.
• Siemens Healthineers

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Thyroid Cancer Diagnostics Market to Reach US$6.7 Billion by 2030

The global market for Thyroid Cancer Diagnostics estimated at US$5.3 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Consumables & Accessories segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 6.8% CAGR

The Thyroid Cancer Diagnostics market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global "Thyroid Cancer Diagnostics" Market - Key Trends & Drivers Summarized

How Is Thyroid Cancer Diagnostics Evolving in the Age of Precision Oncology?

The landscape of thyroid cancer diagnostics is undergoing a significant transformation, driven by advancements in molecular biology, imaging technologies, and personalized medicine. Historically reliant on palpation, ultrasound, and fine-needle aspiration (FNA), thyroid cancer detection is now increasingly supported by genomic profiling, biomarker analysis, and high-resolution imaging. These tools are enhancing diagnostic accuracy, reducing unnecessary surgeries, and enabling earlier detection of malignancies such as papillary and follicular thyroid carcinomas. The use of next-generation sequencing (NGS) panels for identifying mutations in genes like BRAF, RAS, RET, and TERT is revolutionizing how clinicians distinguish between benign and malignant nodules, particularly in cases with indeterminate cytology. Radiomics and AI-based interpretation of ultrasound data are also improving the predictive value of traditional imaging, allowing for more confident clinical decision-making. Liquid biopsies, though still emerging, hold potential for non-invasive, repeatable monitoring of disease progression and recurrence. These technological innovations are not only enhancing diagnostic precision but also supporting the broader trend toward targeted therapies and individualized treatment planning.

Are Rising Thyroid Cancer Rates Changing the Global Diagnostic Priorities?

The global incidence of thyroid cancer has been steadily increasing, particularly in regions with advanced healthcare systems, due in part to widespread use of imaging and increased awareness. This epidemiological trend is prompting public health systems and clinical practices to prioritize the early detection and differentiation of thyroid nodules, many of which are asymptomatic and discovered incidentally during unrelated imaging exams. While much of the increase is attributed to the detection of small, indolent tumors, concerns over overdiagnosis and overtreatment are fueling a shift toward more nuanced diagnostic frameworks. Emerging guidelines advocate for risk-stratified diagnostic approaches that combine imaging features, cytology, and molecular testing to tailor patient management. In Asia, particularly South Korea and China, rising case numbers have led to national screening efforts and increased investment in diagnostic infrastructure. Meanwhile, underserved regions in Africa and parts of Latin America are seeing a delayed but growing demand for diagnostic tools as awareness and access to healthcare improve. These global shifts are reshaping diagnostic workflows and intensifying demand for cost-effective, scalable, and minimally invasive technologies.

What Diagnostic Technologies Are Setting New Standards in Thyroid Cancer Detection?

The diagnostic arsenal for thyroid cancer is expanding rapidly, with innovations that span imaging, cytopathology, and molecular diagnostics. High-frequency ultrasonography remains the cornerstone of initial evaluation, but its diagnostic accuracy is now being significantly enhanced by elastography, Doppler flow analysis, and machine learning algorithms that analyze nodule morphology and vascularity. Fine-needle aspiration biopsy, the gold standard for cytological evaluation, is being supplemented with molecular testing platforms that evaluate panels of gene mutations and expression profiles. Commercial assays such as ThyroSeq, Afirma, and RosettaGX offer valuable insights into the malignancy risk of indeterminate nodules, guiding whether surgery is warranted. SPECT/CT and PET/CT imaging are playing a growing role in staging, recurrence monitoring, and therapy response assessment, particularly in high-risk or metastatic cases. AI-assisted pathology platforms are improving the consistency of cytology interpretation, reducing inter-observer variability. At the frontier, research into circulating tumor DNA (ctDNA) and microRNA signatures in blood promises to add a new layer of non-invasive surveillance. Together, these innovations are moving thyroid cancer diagnostics toward a future defined by accuracy, efficiency, and personalization.

The Growth in the Thyroid Cancer Diagnostics Market Is Driven by Several Factors…

The robust growth in the thyroid cancer diagnostics market is being fueled by a blend of technological, demographic, and healthcare policy-related factors. Rising global incidence of thyroid nodules-many requiring differentiation through advanced diagnostic techniques-is a key clinical driver. Increased use of high-resolution imaging technologies, such as ultrasound and CT scans, is uncovering a larger number of incidental thyroid nodules, many of which are being referred for diagnostic workup. The expanding availability of molecular diagnostics and genomic profiling in routine clinical practice is enabling more precise evaluation of indeterminate cases, thereby reducing diagnostic uncertainty and improving patient management pathways. Moreover, shifting clinical guidelines toward risk-based, personalized approaches to thyroid nodule evaluation are pushing hospitals and diagnostic labs to invest in integrated diagnostic platforms. Patient demand for non-invasive and accurate diagnostics is also influencing the adoption of liquid biopsy and advanced imaging tools. Aging populations, rising healthcare access in emerging economies, and growing awareness about endocrine cancers are further boosting diagnostic volumes. Additionally, the trend toward value-based care and outcome optimization is encouraging providers to adopt technologies that reduce unnecessary procedures and improve diagnostic accuracy, reinforcing the market momentum for advanced thyroid cancer diagnostics.

SCOPE OF STUDY:

The report analyzes the Thyroid Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments, Consumables & Accessories); Test Type (Imaging Test, Biopsy, Blood Test, Other Test Types); End-Use (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Canon Inc.
• Cepheid
• DiaSorin S.p.A.
• Eli Lilly and Company
• FUJIFILM Holdings Corporation
• GE HealthCare
• Hologic Inc.
• Illumina Inc.
• Koninklijke Philips N.V.
• Labcorp
• Merck KGaA
• Myriad Genetics Inc.
• QIAGEN N.V.
• Quest Diagnostics Inc.
• Siemens Healthineers

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Thyroid Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Thyroid Cancer Drives Diagnostic Demand
  • Growing Preference for Non-Invasive Biopsy Techniques Spurs Market Growth
  • Advances in Molecular and Genetic Testing Strengthen Diagnostic Accuracy
  • Expansion of Personalized Treatment Protocols Throws Spotlight on Early Diagnosis
  • AI Integration in Radiology and Ultrasound Accelerates Screening Capabilities
  • Increased Awareness Campaigns Enhance Early Detection Rates
  • Rise in Female Patient Population Expands Addressable Market
  • Innovation in Fine Needle Aspiration Biopsy Tools Drives Market Acceptance
  • Demand for Companion Diagnostics with Targeted Therapies Enhances Adoption
  • Hospital and Diagnostic Lab Expansion in Emerging Markets Sustains Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Thyroid Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cancer Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Associated Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Independent Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Imaging Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• JAPAN
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• CHINA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• EUROPE
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• FRANCE
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• GERMANY
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• INDIA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• AFRICA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030

IV. COMPETITION